Remenar JF - Search Results

1

Performance comparison of a co-crystal of carbamazepine with marketed product.

Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H, Remenar JF, Zhang Z, Tawa MD, Haley S, Zaworotko MJ, Almarsson O. Hickey MB, et al. Among authors: remenar jf. Eur J Pharm Biopharm. 2007 Aug;67(1):112-9. doi: 10.1016/j.ejpb.2006.12.016. Epub 2006 Dec 28. Eur J Pharm Biopharm. 2007. PMID: 17292592

2

Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

Remenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee JM, Guzmán HR, Almarsson O. Remenar JF, et al. J Am Chem Soc. 2003 Jul 16;125(28):8456-7. doi: 10.1021/ja035776p. J Am Chem Soc. 2003. PMID: 12848550

3

High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.

Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR. Morissette SL, et al. Among authors: remenar jf. Adv Drug Deliv Rev. 2004 Feb 23;56(3):275-300. doi: 10.1016/j.addr.2003.10.020. Adv Drug Deliv Rev. 2004. PMID: 14962582 Review.

4

Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.

Remenar JF, Peterson ML, Stephens PW, Zhang Z, Zimenkov Y, Hickey MB. Remenar JF, et al. Mol Pharm. 2007 May-Jun;4(3):386-400. doi: 10.1021/mp0700108. Epub 2007 May 12. Mol Pharm. 2007. PMID: 17497886

5

Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.

Guzmán HR, Tawa M, Zhang Z, Ratanabanangkoon P, Shaw P, Gardner CR, Chen H, Moreau JP, Almarsson O, Remenar JF. Guzmán HR, et al. Among authors: remenar jf. J Pharm Sci. 2007 Oct;96(10):2686-702. doi: 10.1002/jps.20906. J Pharm Sci. 2007. PMID: 17518357

6

Prodrugs of pioglitazone for extended-release (XR) injectable formulations.

Sanrame CN, Remenar JF, Blumberg LC, Waters J, Dean RL, Dong N, Kriksciukaite K, Cao P, Almarsson O. Sanrame CN, et al. Among authors: remenar jf. Mol Pharm. 2014 Oct 6;11(10):3617-23. doi: 10.1021/mp500359a. Epub 2014 Sep 9. Mol Pharm. 2014. PMID: 25157965 Free article.

7

Polymorphism in butylated hydroxy anisole (BHA).

McMahon JA, Zaworotko MJ, Remenar JF. McMahon JA, et al. Among authors: remenar jf. Chem Commun (Camb). 2004 Feb 7;(3):278-9. doi: 10.1039/b311606a. Epub 2004 Jan 6. Chem Commun (Camb). 2004. PMID: 14740036 No abstract available.

8

Delivery of long-acting injectable antivirals: best approaches and recent advances.

Hickey MB, Merisko-Liversidge E, Remenar JF, Namchuk M. Hickey MB, et al. Among authors: remenar jf. Curr Opin Infect Dis. 2015 Dec;28(6):603-10. doi: 10.1097/QCO.0000000000000214. Curr Opin Infect Dis. 2015. PMID: 26524333 Review.

9

Making the leap from daily oral dosing to long-acting injectables: lessons from the antipsychotics.

Remenar JF. Remenar JF. Mol Pharm. 2014 Jun 2;11(6):1739-49. doi: 10.1021/mp500070m. Epub 2014 Apr 30. Mol Pharm. 2014. PMID: 24679167 Review.

10

Solid-state nuclear magnetic resonance determination of the physical form of BHA on common pharmaceutical excipients.

Remenar JF, Wenslow R, Ostovic D, Peresypkin A. Remenar JF, et al. Pharm Res. 2004 Jan;21(1):185-8. doi: 10.1023/b:pham.0000012168.44628.ed. Pharm Res. 2004. PMID: 14984274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page